• Skip to primary navigation
  • Skip to content
  • Skip to footer
  • CBD 101
  • Cannidex Is Different
  • About Direct Effects
  • Clinical Experience
  • Our Mission
  • FAQ
  • Shop

Cannidex

asset-3Buy CANNIDEX™ Online
Applying scientific standards to hemp-derived cannabidiol (CBD)

Wholesale







Footer

  • About Cannidex
  • Contact Us
  • Customer Support
  • References
  • Wholesale
  • mail
  • twitter
  • facebook
  • youtube

Disclaimer

The Food and Drug Administration has not evaluated the statements made regarding CANNIDEX™. The efficacy of CANNIDEX™ has not been confirmed by FDA-approved research and CANNIDEX™ is not intended to diagnose, treat, cure or prevent any disease. No information presented here is intended to be a substitute for, or alternative to, information from a health care provider. Please consult your health care provider about potential interactions or other possible complications before using CANNIDEX™.

CANNIDEX™ is a trademark of Cannidex Brands, LLC. Direct Effects™ is a trademark of AfGin Pharma, LLC.

CANNIDEX™ Brands, LLC is a licensee of United States Patent Application No. 62126757, filed in March 2015 by inventor Ronald Aung-Din and currently pending with the USPTO. This patent covers the application of topical hemp derived CBD at the back-of-the-neck (BON) region through Direct Effects™. No FDA-approved clinical trials have been conducted with any Direct Effects™ CBD topical formulation.

© 2019 CANNIDEX Brands, LLC. All rights reserved.

  • CBD 101
  • Cannidex Is Different
  • About Direct Effects
  • Clinical Experience
  • Our Mission
  • FAQ
  • Shop